AU1127700A - Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation - Google Patents

Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation

Info

Publication number
AU1127700A
AU1127700A AU11277/00A AU1127700A AU1127700A AU 1127700 A AU1127700 A AU 1127700A AU 11277/00 A AU11277/00 A AU 11277/00A AU 1127700 A AU1127700 A AU 1127700A AU 1127700 A AU1127700 A AU 1127700A
Authority
AU
Australia
Prior art keywords
inflammation
solution containing
treating pain
irrigation solution
mapk inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11277/00A
Inventor
Gregory A Demopulos
Jeffrey M Herz
Pamela P. Palmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omeros Corp
Original Assignee
Omeros Medical Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omeros Medical Systems Inc filed Critical Omeros Medical Systems Inc
Publication of AU1127700A publication Critical patent/AU1127700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU11277/00A 1998-10-20 1999-10-20 Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation Abandoned AU1127700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10502698P 1998-10-20 1998-10-20
US60105026 1998-10-20
PCT/US1999/024625 WO2000023072A1 (en) 1998-10-20 1999-10-20 Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation

Publications (1)

Publication Number Publication Date
AU1127700A true AU1127700A (en) 2000-05-08

Family

ID=22303654

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11277/00A Abandoned AU1127700A (en) 1998-10-20 1999-10-20 Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation

Country Status (3)

Country Link
EP (1) EP1261334A1 (en)
AU (1) AU1127700A (en)
WO (1) WO2000023072A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0956018A4 (en) 1996-08-21 2000-01-12 Smithkline Beecham Corp Imidazole compounds, compositions and use
US7301021B2 (en) 1997-07-02 2007-11-27 Smithkline Beecham Corporation Substituted imidazole compounds
KR20080099355A (en) * 1999-07-21 2008-11-12 오메로스 코포레이션 Solutions and methods for inhibition of pain, inflammation and cartilage degradation
US6284790B1 (en) * 2000-06-15 2001-09-04 Sachin Gupte Methods of potentiating organic nitrates having vasodilating activity and formulations for the same
US7998507B2 (en) 2000-09-21 2011-08-16 Elan Pharma International Ltd. Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
US20040122008A1 (en) * 2002-09-05 2004-06-24 Protter Andrew A. Treatment of pain by inhibition of p38 MAP kinase
CA2479737C (en) * 2002-03-20 2011-05-24 Elan Pharma International Ltd. Nanoparticulate compositions of map kinase inhibitors
CA2492033A1 (en) 2002-07-09 2004-01-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
WO2004010894A2 (en) 2002-07-30 2004-02-05 Omeros Corporation Ophthalmologic irrigation solutions and method
US20060035893A1 (en) 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (en) 2004-12-24 2006-10-06 Boehringer Ingelheim Int INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
EP1997798A4 (en) * 2006-03-17 2010-09-29 Nippon Soda Co Method for producing 1,2-phenylethane compound using atom transfer radical coupling reaction
EP2117538A1 (en) 2007-01-24 2009-11-18 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
TWI705812B (en) 2014-12-01 2020-10-01 奥默羅斯公司 Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023039A1 (en) * 1993-04-07 1994-10-13 The Institute Of Cancer Research: Royal Cancer Hospital Methods for screening of substances for therapeutic activity and yeast for use therein
KR100517210B1 (en) * 1994-12-12 2006-06-07 오메로스 코포레이션 Infusion solution for pain, inflammation and spasm
US5525625A (en) * 1995-01-24 1996-06-11 Warner-Lambert Company 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders
JP2000507545A (en) * 1996-03-25 2000-06-20 スミスクライン・ビーチャム・コーポレイション Novel treatment for CNS injury
US6147080A (en) * 1996-12-18 2000-11-14 Vertex Pharmaceuticals Incorporated Inhibitors of p38
WO1999034792A1 (en) * 1998-01-06 1999-07-15 The General Hospital Corporation Use of mek1 inhibitors as protective agents against damage due to ischemia

Also Published As

Publication number Publication date
EP1261334A1 (en) 2002-12-04
WO2000023072A1 (en) 2000-04-27

Similar Documents

Publication Publication Date Title
AU1127700A (en) Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation
AU7696098A (en) Substance p inhibitors in combination with nmda-blockers for treating pain
AU6030799A (en) Treatment of wound or joint for relief of pain and promotion of healing
HUP0004170A3 (en) Methods and materials for treating and preventing inflammation ofmucosal tissue
AU4871099A (en) Stent delivery device and method of use
AU6272199A (en) Surgical dressing with delivery system and method of manufacture
IL117326A0 (en) Regulated flow-restrictor devices particularly useful in drip irrigation
AU1332101A (en) Systems and methods for treating spinal pain
AU5439996A (en) Compositions and methods for treating pain
AU3640997A (en) Iontophoretic delivery of integrin inhibitors
AU7622198A (en) Methods of treating mental diseases, inflammation and pain
EP1009404A4 (en) METHODS FOR TREATING INFLAMMATION AND INFLAMMATORY DISEASES USING pADPRT INHIBITORS
AU7472798A (en) Cox-2 inhibitors in combination with nmda-blockers for treating pain
AU3784999A (en) Methods for treatment of pain
AU1214900A (en) Irrigation solution and method for inhibition of pain and inflammation
AU6260999A (en) Methods of treating chronic pain
AU5929499A (en) A wound treatment composition and a wound dressing containing it
AU5056099A (en) Compounds for use in the treatment of inflammation
AU2512501A (en) Use of trimebutine for treating pain
AU7143896A (en) Heat-removable bandage and medical tape
IL138594A0 (en) Use of protease inhibitors for treating skin wounds
AU1214800A (en) Irrigation solution and method for inhibition of pain and inflammation
AU5528299A (en) Combined therapy for treatment of inflammation using elastase inhibitor(s) and antibacterial agent(s)
AU7688998A (en) Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
AU2372400A (en) Egg anti-inflammatory composition and method of treating and preventing inflammation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase